THE ROLE OF NEPHROBIOPSY IN THE VERIFICATION OF STEROID-RESISTANT NEPHROTIC SYNDROME IN CHILDREN

https://storage.unitedwebnetwork.com/files/1099/694310437fcebdb480d5b29a9a49a517.pdf
THE ROLE OF NEPHROBIOPSY IN THE VERIFICATION OF STEROID-RESISTANT NEPHROTIC SYNDROME IN CHILDREN
Natalya S.
Zhuravleva
Olga A. Vorobyeva olvorob70@gmail.com National Center of Clinical Morphological Diagnostics Head of the Department of Nephropathology and Complex Morphological Diagnosis St. Petersburg
Nikita S. Permyakov drakewilson1337@yandex.ru Ural State Medical University Faculty of Pediatrics Ekaterinburg
Diane I. Titova titova23@inbox.ru Ural State Medical University Faculty of Pediatrics Ekaterinburg
Natalya Yu. Mineeva mineevany@mis66.ru Regional Children's Clinical Hospital nephrological Ekaterinburg
Anastasia S. Telina p-asja@mail.ru Regional Children's Clinical Hospital nephrological Ekaterinburg
Svetlana E. Baum s.e.savina1995@gmail.com Regional Children's Clinical Hospital nephrological Ekaterinburg
Sergei A. Khoroshev horoshevsa@inbox.ru Regional Children's Clinical Hospital nephrological Ekaterinburg
Marina V. Makarovskaya makarovskayamv@mis66.ru Regional Children's Clinical Hospital deputy Chief Physician Ekaterinburg
Oleg Yu. Averyanov odkb-public@mis66.ru Regional Children's Clinical Hospital chief medical officer Ekaterinburg
 
 
 
 
 
 

Introduction. Nephrotic syndrome (NS) is one of the most severe renal pathologies resulting in terminal renal failure. NS often relapses and becomes resistant to immunosuppressive therapy. It is relevant to analyze the course of idiopathic steroid-resistant nephrotic syndrome in children (SRNS) who received immunosuppressive therapy.

Objective: to analyze the course and morphologic verification of steroid-resistant nephrotic syndrome (SRNS) in children.

Materials and Methods. We retrospectively analyzed the history, clinical and laboratory manifestations, and morphologic changes of kidney tissue in 20 children with steroid-resistant nephrotic syndrome between 2021 and 2023.

Results. The study group consisted of 55.0% boys and 45.0% girls aged 6 months to 17 years (mean age 9.8±3.7 years, Me-10.5 years, σ-3.8). Family history of urinary system diseases was aggravated in half of the children (45.5%). The mean age of disease debut was 5±0.6 years (min-6 months, max-10.3, Me-4.8y, σ-2.3y); mean disease duration was 4.44±0.6 years (Me-4.5y, σ-2.9y). At the time of nephrobiopsy, edema was noted in 35% of children; hypertension in 15%; mean proteinuria was 2.5±3.2 g/day; proteinemia 49.8±16.6 g/L, albuminemia 29.1±11.4 g/L, and blood cholesterol 7.1±3.2 mmol/L. Herpetic infection persisted in 28.4% of cases. At the time of examination, the majority of children (75.0%) had stage I chronic kidney disease, 20.0% had stage III chronic kidney disease, and one child had stage V chronic kidney disease. In the debut of the disease, no effect of steroid therapy at a dose of 2 mg/kg per day for 6 weeks was noted in 100% of children. According to light-optical, immunofluorescence, electron-microscopic studies of nephrobiopsy specimens, diffuse non-immunocomplex podocytopathy with splitting of small outgrowths of podocytes (from 60% to 100%) prevailed (80.0%); in two children - with the formation of focal segmental glomerulosclerosis. Diffuse membranous nephropathy (5%), complement-associated renal tissue lesions from the group of C3-glomerulopathies (5%); ultrastructural damage to the glomerular basal membrane (GBM) pathognomonic for collagen type IV pathology (5%) were detected in single cases. Subglobular glomerulosclerosis (100%); disorder of anatomical histoarchitectonics and differentiation of the tubule apparatus with sharp pseudocystic dilatation of the lumen; total acute damage of the tubule epithelium were verified in a six-month-old girl.

Molecular genetic study was performed in 2 patients using next-generation sequencing technology: in one child with GBM ultrastructural pathology, a relevant mutation variant of the COL4A5 gene was detected; in the second, with nonimmunocomplex podocytopathy, no pathogenic gene variants were detected. 

Conclusion. Most children with SRNS had predominantly (75.0%) diffuse non-immunocomplex podocytopathy with stratification of small podocyte outgrowths, requiring genetic testing for pathology of functional podocyte proteins. Focal segmental glomerulosclerosis (5%); diffuse membranous nephropathy (5%), complement-associated renal tissue lesions from the group of C3-glomerulopathies (5%); ultrastructural damage of glomerular basal membrane (GBM) pathognomonic for collagen type IV pathology (5%) was detected in single cases.

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos